Advisers to the Food and Drug Administration are backing popular peptide therapies. They voted to allow specialized pharmacies to make them despite agency scientists' recommendations against it.
<iframe src="https://statesidedaily.com/embed/cluster/ef16ba4983b7cbca4bae1506772e5f1624d80b63" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="FDA panel backs easier access to peptides"></iframe>
Advisers to the Food and Drug Administration voted in favor of easing regulation of popular peptides. The recommendations could pave the way for specialized pharmacies to produce them in the U.S.
